Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the following medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
Schedule
Product: Januvia
Active Ingredient: Sitagliptin phosphate 128.5mg equivalent to 100mg sitagliptin
Dosage Form: Film coated tablet
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer: Merck Sharp & Dohme SpA, Pavia, Italy
Product: Januvia
Active Ingredient: Sitagliptin phosphate 32.13mg equivalent to 25mg sitagliptin
Dosage Form: Film coated tablet
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer: Merck Sharp & Dohme SpA, Pavia, Italy
Product: Januvia
Active Ingredient: Sitagliptin phosphate 64.25mg equivalent to 50mg sitagliptin
Dosage Form: Film coated tablet
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer: Merck Sharp & Dohme SpA, Pavia, Italy
Dated this 27th day of February 2009.
STUART POWELL, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).